Mirxes Holding Company Limited reported that the Hong Kong Stock Exchange (HKEX) has issued six specific resumption conditions following the suspension of its shares on 1 April 2026.
Key resumption requirements 1. Independent forensic investigation: Mirxes must complete and disclose an investigation into fourteen prepayments totaling approximately US$14.00 million made in FY2025, related post-year-end cash outflows, and any similar transactions, and implement remedial actions. 2. Management integrity: The company must prove no regulatory concerns exist regarding senior executives or influential parties. 3. Internal controls: An external consultant must confirm all material control deficiencies have been rectified and that Listing Rule compliance procedures are effective. 4. Financial reporting: All outstanding results must be published and any audit modifications addressed. 5. Listing Rule 13.24 compliance: Mirxes must demonstrate it has a viable business and sufficient operations. 6. Market disclosure: Full disclosure of all information material to investors is required.
Delisting clock and reporting obligations • Under Rule 6.01A(1), HKEX may cancel the listing if trading is not resumed within 18 months; Mirxes faces a hard deadline of 30 September 2027. • Quarterly progress updates are mandatory, with the first report due by 1 July 2026.
Audit triggers for suspension KPMG, the group’s auditor, delayed signing off FY2025 accounts after flagging: • Fourteen prepayments to multiple vendors amounting to US$14.00 million. • Insufficient evidence on the commercial rationale, vendor relationships, procurement compliance and pricing of those prepayments. • “Material” post-31 December 2025 cash outflows whose business purpose remains unverified.
Governance measures • An Independent Investigation Committee (IIC) is overseeing the forensic review and will seek KPMG’s validation that findings fully address audit issues. • Somerley Capital Limited continues as compliance adviser throughout the remedial period.
Trading status Mirxes shares remain suspended; any further updates will be disclosed in accordance with Listing Rules. Investors are advised to exercise caution when dealing in the company’s securities.
Comments